FDA approves ArkBio’s ziresovir for Phase II trial in severe RSV Clinical Trials Arena 10:57 Mon, 17 Aug
ArkBio's Rsv Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial PR Newswire (Press Release) 11:10 Fri, 14 Aug
ArkBio Announces China Ind Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis PR Newswire (Press Release) 02:03 Thu, 13 Aug
